Other studies employing microarray technology have evaluated gene expression profiling of E. coli in the context of phylogenetic studies [11] [14], [31] and in response to either different environmental growth conditions or varying growth media [15] [20].
Of note, negative studies used microarray technology or evaluated specific genes.
The survey was also designed to determine how various organizations are using microarray technology to evaluate the safety of chemicals and drugs regarding public health and regulatory assessment, the types of applications both in vivo and in vitro, the resources required, and the data-management challenges and solutions.
DNA microarray technology, a high throughput technology evaluates the expression of thousands of genes simultaneously under different experimental conditions.
None of the two studies using microarrays technologies reported evaluating potential batch effects [ 29, 53].
Microarray technology was used to evaluate miRNA profile in 24 male and 43 female fBC.
Similarly to microarray technology, SAGE can be used to evaluate genome-wide transcriptional response of a given-cell, tissue, or organ to environmental stimuli.
We shall present the detailed outcome of using the SVM classifier and the Gaussian process classifier in the task of distinguishing between the three classes, BRCA1 and BRCA2 mutation carriers and noncarriers, and evaluate whether this microarray technology can be used to facilitate the clinical detection and classification of mutations.
Gene expression microarray technology is an important tool for evaluating tumor heterogeneity and has been successfully applied to identify subsets of tumors (including within ESCC) with different clinical parameters such as survival, histological grade, invasive status, and response to therapy [ 10– 15].
The development of microarray technology has greatly enhanced our ability to evaluate gene expression.
